EUVIMEDEUVIMED entdecken
Crossref

Sensitive and quantitative in vivo analysis of PD-L1 using magnetic particle imaging and imaging-guided immunotherapy

Zhengyao Peng, Chang Lu, Guangyuan Shi, Lin Yin, Xiaolong Liang, Guosheng Song, Jie Tian, Yang Du

European Journal of Nuclear Medicine and Molecular Imaging · 2023-04 · 50 (5) · 1291-1305

DOI: 10.1007/s00259-022-06083-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 12.12.2022. Verfasst von Zhengyao Peng und 7 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Molecular Imaging, Beijing Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, …. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality, Shenzhen Science and Technology Innovation Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The programmed cell death protein-1 (PD-1) and programmed cell death ligand-1 (PD-L1) expression correlate with the immunotherapeutic response rate. The sensitive and non-invasive imaging of immune checkpoint biomarkers is favorable for the accurate detection and characterization, image-guided immunotherapy in cancer precision medicine. Magnetic particle imaging (MPI), as a novel and emerging imaging modality, possesses the advantages of high sensitivity, no image depth limitation, positive contrast, and absence of radiation. Hence, in this study, we performed the pioneer investigation of monitoring PD-L1 expression using MPI and the MPI-guided immunotherapy. METHODS: We developed anti-PD-L1 antibody (aPDL1)-conjugated magnetic fluorescent hybrid nanoparticles (MFNPs-aPDL1) and utilized MPI in combination with fluorescence imaging (FMI) to dynamically monitor and quantify PD-L1 expression in various tumors with different PD-L1 expression levels. The ex vivo real-time polymerase chain reaction (qPCR), western blotting, and immunofluorescence staining analysis were further performed to validate the in vivo imaging observation. Moreover, the MPI was further performed for the guidance of immunotherapy. RESULTS: Our data showed that PD-L1 expression can be specifically and sensitively monitored and quantified using MPI and FMI imaging methods, which were validated by ex vivo qPCR and western blotting analysis. In addition, MPI-guided PD-L1 immunotherapy can enhance the effectiveness of cancer immunotherapy. CONCLUSION: To our best knowledge, this is the pioneer study to utilize MPI in combination with a newly developed MFNPs-aPDL1 imaging probe to dynamically visualize and quantify PD-L1 expression in tumor microenvironment. This imaging strategy may facilitate the clinical optimization of immunotherapy management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansImmunotherapyMagnetic PhenomenaOptical ImagingTumor MicroenvironmentProgrammed Cell Death 1 Receptor

Stichwörter der Autor:innen

Fluorescence imagingImmunotherapyMagnetic particle imagingMolecular imagingPD-L1

Substanzen

Programmed Cell Death 1 Receptor

Autor:innen und Institutionen

  • CAS Key Laboratory of Molecular Imaging, Beijing Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.
  • University of Chinese Academy of Sciences, Beijing, 100080, China.
  • State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Shenzhen Research Institution of Hunan University, Hunan University, Changsha, 410082, China.
  • University of Science and Technology of China, Hefei, 230026, China.
  • Department of Ultrasound, Peking University Third Hospital, Beijing, 100191, China.
  • State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Shenzhen Research Institution of Hunan University, Hunan University, Changsha, 410082, China. songgs@hnu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Beijing Municipality
  • Shenzhen Science and Technology Innovation Program
  • Key Technologies Research and Development Program

Zitieren

APA

Peng, Z., Lu, C., Shi, G., Yin, L., Liang, X., Song, G., Tian, J., & Du, Y. (2023). Sensitive and quantitative in vivo analysis of PD-L1 using magnetic particle imaging and imaging-guided immunotherapy. European Journal of Nuclear Medicine and Molecular Imaging, 50(5), 1291-1305. https://doi.org/10.1007/s00259-022-06083-2

Vancouver

Peng Z, Lu C, Shi G, Yin L, Liang X, Song G, et al. Sensitive and quantitative in vivo analysis of PD-L1 using magnetic particle imaging and imaging-guided immunotherapy. European Journal of Nuclear Medicine and Molecular Imaging. 2023;50(5):1291-1305. doi:10.1007/s00259-022-06083-2

BibTeX
@article{Peng2023,
  author = {Peng, Zhengyao and Lu, Chang and Shi, Guangyuan and Yin, Lin and Liang, Xiaolong and Song, Guosheng and Tian, Jie and Du, Yang},
  title = {Sensitive and quantitative in vivo analysis of PD-L1 using magnetic particle imaging and imaging-guided immunotherapy},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2023},
  volume = {50},
  number = {5},
  pages = {1291--1305},
  doi = {10.1007/s00259-022-06083-2}
}
Kostenlos starten →